Issue 2, 2005

Natural products to drugs: natural product derived compounds in clinical trials

Abstract

Covering: 31st December 2004

Natural product and natural product-derived compounds that are being evaluated in clinical trials or in registration (current 31 December 2004) have been reviewed. Natural product derived drugs launched in the United States of America, Europe and Japan since 1998 and new natural product templates discovered since 1990 are discussed.

Graphical abstract: Natural products to drugs: natural product derived compounds in clinical trials

Additions and corrections

Article information

Article type
Review Article
Submitted
13 Jan 2005
First published
08 Mar 2005

Nat. Prod. Rep., 2005,22, 162-195

Natural products to drugs: natural product derived compounds in clinical trials

M. S. Butler, Nat. Prod. Rep., 2005, 22, 162 DOI: 10.1039/B402985M

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements